Metabolic and hepatic safety in ART experienced PLWH switching to a DOR-based regimen vs rilpivirine. Data from a real-life setting

Conference Reports for NATAP

HIV Glasgow 2022
23-26 October
Virtual Meeting


Metabolic and hepatic safety in ART experienced PLWH switching to a DOR-based regimen vs rilpivirine. Data from a real-life setting

	Glasgow 2022 Oct 23-26